Director of CARB-X Kevin Outterson predicts hard times for antibiotic drug development companies - Antibiotic Research UK
At the All Party Parliamentary Group Meeting on antibiotics held in the Palace of Westminster on 13 November 2018 (unfortunately not attended by many MPs or members of the House of Lords) Kevin Outterson, director of CARB-X presented on the parlous state of small US biotech companies working in the antibiotic development space. He showed that for six US companies ... Read More